Rastreamento de câncer cervical

Referências

Principais artigos

US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018 Aug 21;320(7):674-86.Texto completo  Resumo

Artigos de referência

1. Wright TC Jr. Cervical cancer screening in the 21st century: is it time to retire the PAP smear? Clin Obstet Gynecol. 2007;50:313-323. Resumo

2. Anderson MC. Female reproductive system. Systemic pathology, vol 6, 3rd ed. London, UK: Churchill Livingston; 1991.

3. Walton RJ, Blanchet M, Boyes DA, et al. Cervical cancer screening programs: I. Epidemiology and natural history of carcinoma of the cervix. Can Med Assoc J. 1976;114:1003-1012.Texto completo  Resumo

4. Clarke EA, Anderson TW. Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 1979;2:1-4. Resumo

5. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81:159-166.Texto completo  Resumo

6. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology. 2006;17:127-136. Resumo

7. Smith AE, Sherman ME, Scott DR, et al. Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears. Cancer Cytopathol. 2000;90:201-206.Texto completo  Resumo

8. Quddus MR, Sung CJ, Steinhoff MM, et al. Atypical squamous metaplastic cells: reproducibility, outcome, and diagnostic features on ThinPrep Pap test. Cancer Cytopathol. 2001;93:16-22.Texto completo  Resumo

9. Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111:167-177. Resumo

10. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.Texto completo  Resumo

11. Coste J, Cochand-Priollet B, de Cremoux P, et al. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ. 2003;326:733.Texto completo  Resumo

12. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119. Resumo

13. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003;95:1336-1343.Texto completo  Resumo

14. Melnikow J, Nuovo J, Willan AR, et al. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92:727-735. Resumo

15. Arbyn M, Buntinx F, Van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst. 2004;96:280-293.Texto completo  Resumo

16. Holschneider CH. Human papillomavirus and the management of the abnormal Pap test. In: Gibbs RS, Karlan BY, Haney AF, et al, eds. Danforth's obstetrics and gynecology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:989-1001.

17. Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17:1611-1622.Texto completo  Resumo

18. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518-27.Texto completo  Resumo

19. Cuzick J, Beverly E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer. 1999;81:554-558.Texto completo  Resumo

20. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-1392. Resumo

21. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188:1393-1400. Resumo

22. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079.Texto completo  Resumo

23. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385-1394.Texto completo  Resumo

24. Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 Jul 30 [Epub ahead of print].Texto completo  Resumo

25. Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136:178-182. Resumo

26. Sawaya GF, Kulasingam S, Denberg TD, et al. Cervical cancer screening in average-risk women: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2015;162:851-859.Texto completo  Resumo

27. Wodi AP, Murthy N, Bernstein H, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger — United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:234–7.Texto completo

28. Murthy N, Wodi AP, Bernstein H, et al. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:229–33.Texto completo

29. UK Health Security Agency. HPV vaccination: guidance for healthcare practitioners. Apr 2022 [internet publication].Texto completo

30. Szurkus DC, Harrison TA. Loop excision for high-grade squamous intraepithelial lesion on cytology: correlation with colposcopic and histologic findings. Am J Obstet Gynecol. 2003;188:1180-1182. Resumo

31. Arbyn M, Herbert A, Schenck U, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology. 2007;18:133-139.Texto completo  Resumo

32. Herbert A, Bergeron C, Wiener H, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology. 2007;18:213-219. Resumo

33. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018 Aug 21;320(7):674-86.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal